Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon inflammatory disease of
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …
the central nervous system, manifesting clinically as optic neuritis, myelitis, and certain brain …
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)–revised recommendations of the Neuromyelitis Optica Study Group …
S Jarius, O Aktas, I Ayzenberg, J Bellmann-Strobl… - Journal of …, 2023 - Springer
The term 'neuromyelitis optica spectrum disorders'(NMOSD) is used as an umbrella term that
refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) …
refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) …
Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review
L Amezcua, VM Rivera, TC Vazquez… - JAMA …, 2021 - jamanetwork.com
Importance There is empirical evidence that social determinants of health (SDOH) impact
health outcomes in Black and Hispanic and Latinx individuals in the US. Recently, SDOH …
health outcomes in Black and Hispanic and Latinx individuals in the US. Recently, SDOH …
[HTML][HTML] Neuromyelitis optica spectrum disorders
S Huda, D Whittam, M Bhojak, J Chamberlain… - Clinical Medicine, 2019 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is an uncommon antibody-mediated
disease of the central nervous system. Long segments of spinal cord inflammation (myelitis) …
disease of the central nervous system. Long segments of spinal cord inflammation (myelitis) …
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
K Fujihara, JL Bennett, J de Seze… - Neurology …, 2020 - AAN Enterprises
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disorder that
preferentially affects the spinal cord and optic nerve. Most patients with NMOSD experience …
preferentially affects the spinal cord and optic nerve. Most patients with NMOSD experience …
Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis
Neuromyelitis optica spectrum disorders (NMOSD) are autoantibody mediated chronic
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …
inflammatory diseases. Serum antibodies (Abs) against the aquaporin-4 water channel lead …
Long-term effectiveness and safety of rituximab in neuromyelitis optica spectrum disorder and MOG antibody disease
Background and Objectives Rituximab is used widely for relapse prevention in neuromyelitis
optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG …
optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG)-IgG …
AQP4-IgG and MOG-IgG related optic neuritis—prevalence, optical coherence tomography findings, and visual outcomes: a systematic review and meta-analysis
Background: Optic neuritis (ON) is a cardinal manifestation of multiple sclerosis (MS),
aquaporin-4 (AQP4)-IgG-, and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated …
aquaporin-4 (AQP4)-IgG-, and myelin oligodendrocyte glycoprotein (MOG)-IgG-associated …
Inebilizumab: first approval
JE Frampton - Drugs, 2020 - Springer
Inebilizumab (Uplizna™; inebilizumab-cdon in the USA) is a humanised anti-CD19
monoclonal antibody being developed by Viela Bio for the treatment of a range of …
monoclonal antibody being developed by Viela Bio for the treatment of a range of …
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice
EC Contentti, JI Rojas, E Cristiano, VD Marques… - Multiple sclerosis and …, 2020 - Elsevier
Background During the last two decades, neuromyelitis optica spectrum disorder (NMOSD)
has undergone important changes, with new diagnostic markers and criteria, better …
has undergone important changes, with new diagnostic markers and criteria, better …